Skip to main content

Want a detailed portfolio tracker?

Calidi Biotherapeutics (CLDI) P/E (2022 - 2026)

Calidi Biotherapeutics (CLDI) P/E from Sep 30, 2022 to Jul 20, 2026. The TTM Calidi Biotherapeutics (CLDI) P/E is -0.03. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Calidi Biotherapeutics (CLDI)

YearP/EChange
2026-0.03-85.95%
2025-0.23-86.52%
2024-1.68-66.63%
2023-5.03-93.59%
2022-78.44N/A

Comparison Calidi Biotherapeutics (CLDI) P/E with competitors

Calidi Biotherapeutics (CLDI) P/E is -0.03.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-105.36%
NBYStablecoin Development Corp0.00-113.55%
ENLVEnlivex Ltd0.07-335.65%
FGENFibroGen Inc0.24-856.19%
CHRSCoherus Biosciences Inc0.85-2773.09%
FBIOFortress Biotech Inc0.95-3089.70%
ORMPOramed Pharmaceuticals Inc1.50-4835.01%
AGENAgenus Inc3.01-9581.04%
INVAInnoviva Inc3.15-10035.95%
VXRTVaxart Inc3.55-11282.55%
CRMDCorMedix Inc3.63-11530.49%
CVACCureVac N.V.4.45-14104.97%
GLPGGalapagos NV4.86-15406.70%
SRPTSarepta Therapeutics Inc4.88-15479.79%
ABEOAbeona Therapeutics Inc5.39-17071.99%
ABUSArbutus Biopharma Corp5.60-17727.58%
ZVRAZevra Therapeutics Inc5.89-18646.22%
SPROSpero Therapeutics Inc6.23-19721.13%
CGENCompugen Ltd6.31-19990.49%
RIGLRigel Pharmaceuticals6.87-21748.71%
SLXNSilexion Therapeutics Corp7.30-23084.47%
OMEROmeros Corporation9.26-29267.38%
AUPHAurinia Pharmaceuticals Inc9.58-30295.03%
PLXProtalix BioTherapeutics Inc10.89-34409.41%
ACADAcadia Pharmaceuticals Inc11.73-37047.85%
TBPHTheravance Biopharma Inc12.26-38728.88%
ADMAAdma Biologics Inc12.42-39220.34%
HRMYHarmony Biosciences Holdings Inc13.82-43637.16%
SABSSAB Biotherapeutics Inc14.14-44632.68%
NAGENiagen Bioscience Inc14.82-46780.91%
INCYIncyte Corp15.82-49945.15%
REGNRegeneron Pharmaceuticals Inc15.86-50052.57%
PBYIPuma Biotechnology Inc17.32-54648.96%
CPRXCatalyst Pharmaceuticals Inc17.44-55038.35%
EXELExelixis Inc17.54-55349.29%
TGTXTG Therapeutics Inc18.97-59848.02%
MDXGMimedx Group Inc20.55-64845.76%
XOMAXOMA Royalty Corp22.87-72163.13%
ARGXArgen X SE24.30-76647.05%
CTMXCytomX Therapeutics Inc24.82-78295.00%
XOMAOXOMA Royalty Corp25.34-79944.85%
HALOHalozyme Therapeutics Inc25.62-80823.49%
XOMAPXOMA Royalty Corp25.67-80969.67%
VRTXVertex Pharmaceuticals Inc27.99-88293.02%
RPRXRoyalty Pharma plc - Class A28.69-90475.59%
SLNOSoleno Therapeutics Inc29.02-91508.28%
ASNDAscendis Pharma A/S30.09-94879.81%
LGNDLigand Pharmaceuticals Inc - Class B37.91-119535.86%
APLSApellis Pharmaceuticals Inc39.02-123030.25%
BMRNBiomarin Pharmaceutical Inc42.21-133081.82%
KRYSKrystal Biotech Inc45.34-142947.52%
ONCBeiGene Ltd69.54-219176.38%
PHARPharming Group N.V.75.03-236456.47%
TECHBio-Techne Corp101.96-321304.11%
VCELVericel Corp109.92-346390.18%
ALNYAlnylam Pharmaceuticals Inc117.96-371730.81%
GMABGenmab140.29-442064.38%
TLXTelix Pharmaceuticals Ltd162.15-510937.44%
CORTCorcept Therapeutics Inc212.86-670674.72%